Friday, October 23, 2020
Home Life Style Health & Fitness Common Diabetes Drug Associated With Lower Heart Issues

Common Diabetes Drug Associated With Lower Heart Issues

These findings suggest that SGLT2 inhibitors offer cardioprotective benefits among people with type 2 diabetes

Drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with a lower risk of major heart problems in patients with type 2 diabetes than dipeptidyl peptidase-4 (DPP-4) inhibitors, say, researchers.

According to the study, published in the journal The BMJ, previous trials have shown that SGLT2 inhibitors can reduce the risk of heart conditions such as heart attack, stroke, and heart failure compared with placebo.

Follow NewsGram on Twitter to stay updated about the World news.

But some of these trials had important limitations, making it difficult to interpret the results, and data on the effects of individual SGLT2 inhibitors on the heart are limited.

Common diabetes drug linked to low risk of major heart issues
Major cardiovascular events, as well as heart failure and death from any cause, were recorded for an average of 11 months. Unsplash

So the research team from McGill University in Canada set out to compare the risk of cardiovascular events between SGLT2 inhibitors and DPP-4 inhibitors among adults with type 2 diabetes in a “real world” clinical practice setting.

Their findings are based on healthcare data from seven Canadian provinces and the UK from 2013-18 (a total of 209,867 new users of an SGLT2 inhibitor matched to 209,867 users of a DPP-4 inhibitor).

Major cardiovascular events (a combination of heart attack, stroke or cardiovascular death), as well as heart failure and death from any cause, were recorded for an average of 11 months.

Compared with DPP-4 inhibitors, SGLT2 inhibitors were associated with a reduced risk of heart attack, stroke or cardiovascular death combined (11.4 events per 1000 person years vs 16.5 events per 1000 person years).

Common diabetes drug linked to low risk of major heart issues
According to the researchers, results were similar in subgroups defined by patient age, sex, past insulin use, and history of cardiovascular disease. Unsplash

“SGLT2 inhibitors were also associated with decreased risks of individual events,”

the researchers wrote.

According to the researchers, results were similar in subgroups defined by patient age, sex, past insulin use, and history of cardiovascular disease. This is an observational study and the researchers point to some limitations, such as relying on prescription data over a relatively short follow-up period.

Also Read: Thinking of Investing? Your Career May Be the Best Place to Start

They cannot rule out the possibility that other unmeasured (confounding) factors may have affected their results. However, results were consistent across several analyses, suggesting that they withstand scrutiny.

These findings suggest that SGLT2 inhibitors offer cardioprotective benefits among people with type 2 diabetes in a real-world setting, although additional studies are needed to determine if these benefits persist long term. (IANS)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,781FollowersFollow

Most Popular

Down Syndrome May Increase COVID Death Risk

Researchers have found that down syndrome is associated with a 10-fold increased risk for COVID-19-related death. Down syndrome (sometimes called Down's syndrome) is a condition...

Miss India 2020 Pageant Held Virtually Due to Pandemic

In the wake of the COVID-19 pandemic, Miss India 2020 pageant will be held virtually the Miss India Organisation has announced. A nationwide audition to...

6 Designers Came Together to Help Craft Clusters Impacted by Pandemic

Six fashion designers came together to support marginalized craft clusters and those heavily impacted by the pandemic by generating livelihood opportunities for the artisans....

India Rapidly Expanding High Power Supercomputers

India is fast expanding its supercomputer facilities and developing the capacity to manufacture its own supercomputers in the country, the Ministry of Science and...

Cholesterol Medications May Lower Cancer-Related Deaths in Women

Among women with breast cancer, colorectal cancer, or melanoma, those who are taking cholesterol-lowering medications are less likely to die from cancer, researchers said. The...

Immediate Biomedical Waste Management Halts COVID Spread: UNIDO

The United Nations Industrial Development Organisation (UNIDO) on Tuesday stressed the need to halt the spread of COVID-19 through all possible infection channels, including...

1.16L Infant Deaths in 2019 Due to Air Pollution in India

The first-ever comprehensive analysis of air pollution's global impact on newborns finds that outdoor and household particulate matter pollution contributed to the deaths of...

Literature and Movies: Filmmaker Suman Mukhopadhyay

While reading 'Chuti Nakoch', a story by writer Ashapurna Devi, he suddenly felt grabbed by the jugular. It was tough to ignore the visual...

Recent Comments